BioRestorative Therapies, Inc. (BRTX) is the 151st largest of 157 Gene and Cell Therapy companies by market capitalisation, at 1.21 Mn, behind Creative Medical Technology Holdings, Inc. at 1.45 Mn. The table below compares all 157 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 10.27 Bn | 42.55 | 23.32 | 9.43 Bn |
| 2 | CRSP | CRISPR Therapeutics AG | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 5.17 Bn | -10.68 | 385.71 | 5.17 Bn |
| 3 | IOVA | Iovance Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -18.13 | 11.66 | 3.49 Bn |
| 4 | LEGN | Legend Biotech Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.68 Bn | -174.54 | 2.89 | 2.71 Bn |
| 5 | QURE | uniQure N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.05 Bn | -15.49 | 163.16 | 3.05 Bn |
| 6 | BEAM | Beam Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | -30.97 | 16.96 | 2.65 Bn |
| 7 | PGEN | Precigen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -7.26 | 28.50 | 2.44 Bn |
| 8 | SRPT | Sarepta Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -16.97 | 1.18 | 1.53 Bn |
| 9 | VCEL | Vericel Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | 79.32 | 6.50 | 1.83 Bn |
| 10 | TSHA | Taysha Gene Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.97 Bn | -13.18 | 359.62 | 1.97 Bn |
| 11 | NTLA | Intellia Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | -4.11 | 27.59 | 1.64 Bn |
| 12 | SLDB | Solid Biosciences Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | -6.75 | — | 1.38 Bn |
| 13 | MGTX | MeiraGTx Holdings plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | 7.34 | 3.02 | 1.07 Bn |
| 14 | IMTX | Immatics N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -4.64 | 22.98 | 0.66 Bn |
| 15 | FDMT | 4D Molecular Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | -5.55 | 10.80 | 0.63 Bn |
| 16 | SANA | Sana Biotechnology, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -4.42 | — | 0.95 Bn |
| 17 | CADL | Candel Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -13.81 | — | 0.91 Bn |
| 18 | NGNE | Neurogene Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.85 Bn | -7.64 | — | 0.85 Bn |
| 19 | IMMX | Immix Biopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -24.76 | — | 0.78 Bn |
| 20 | PRME | Prime Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -3.26 | 150.33 | 0.61 Bn |
| 21 | BNTC | Benitec Biopharma Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -12.40 | — | 0.57 Bn |
| 22 | ALLO | Allogene Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -3.44 | 122.99 | 0.57 Bn |
| 23 | IRD | Opus Genetics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 24 | AUTL | Autolus Therapeutics plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -2.10 | 4.81 | 0.34 Bn |
| 25 | CAPR | Capricor Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -3.97 | — | 0.50 Bn |
| 26 | KYTX | Kyverna Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -3.04 | — | 0.46 Bn |
| 27 | RGNX | REGENXBIO Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.60 | 2.44 | 0.36 Bn |
| 28 | CABA | Cabaletta Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -2.39 | — | 0.44 Bn |
| 29 | ARTV | Artiva Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.68 | — | 0.42 Bn |
| 30 | IPSC | Century Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -3.80 | — | 0.16 Bn |
| 31 | RCKT | Rocket Pharmaceuticals, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -23.71 | — | 0.41 Bn |
| 32 | LXEO | Lexeo Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -4.41 | — | 0.38 Bn |
| 33 | OCGN | Ocugen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -4.39 | 78.38 | 0.26 Bn |
| 34 | PROK | Prokidney Corp. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.35 Bn | -2.59 | 423.07 | 0.35 Bn |
| 35 | ABEO | Abeona Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.06 | 12.95 | 0.18 Bn |
| 36 | CLLS | Cellectis S.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -7.50 | 5.28 | 0.14 Bn |
| 37 | LYEL | Lyell Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.22 | 11,093.57 | 0.30 Bn |
| 38 | FATE | Fate Therapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.33 | 45.07 | 0.29 Bn |
| 39 | NWBO | Northwest Biotherapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -7.08 | 126.60 | 0.27 Bn |
| 40 | LCTX | Lineage Cell Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -11.32 | 19.83 | 0.20 Bn |
| 41 | RNAC | Cartesian Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -2.38 | 175.17 | 0.26 Bn |
| 42 | EDIT | Editas Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | — | — | 0.11 Bn |
| 43 | MEOBF | Mesoblast Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -4.28 | 2.05 | 0.14 Bn |
| 44 | TARA | Protara Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | -3.34 | — | 0.23 Bn |
| 45 | NKTX | Nkarta, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.50 | — | 0.21 Bn |
| 46 | VYGR | Voyager Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -2.37 | 5.65 | 0.08 Bn |
| 47 | DTIL | Precision Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -5.46 | 4.12 | 0.10 Bn |
| 48 | ZSQR | Z Squared Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -7.70 | 53.11 | 0.13 Bn |
| 49 | ATRA | Atara Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -6.29 | 23.87 | 0.13 Bn |
| 50 | CRBU | Caribou Biosciences, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.33 | 14.54 | 0.03 Bn |
| 51 | TNYA | Tenaya Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 107.84 | 0.14 Bn |
| 52 | HUMA | Humacyte, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.15 | 64.72 | 0.14 Bn |
| 53 | ENGN | enGene Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -0.99 | — | 0.13 Bn |
| 54 | ACET | Adicet Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.03 | — | -0.02 Bn |
| 55 | ANIX | Anixa Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.22 | — | 0.10 Bn |
| 56 | INMB | Inmune Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.28 | — | 0.05 Bn |
| 57 | INKT | MiNK Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -5.15 | — | 0.06 Bn |
| 58 | APTN | Adaptin Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -10.22 | — | 0.06 Bn |
| 59 | SGMOQ | Sangamo Therapeutics, Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 1.11 | 0.02 Bn |
| 60 | MGX | Metagenomi Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.47 | 2.02 | 0.04 Bn |
| 61 | TCRX | TScan Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 6.03 | 0.04 Bn |
| 62 | CELU | Celularity Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.42 | 1.44 | 0.03 Bn |
| 63 | ESLA | Estrella Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.88 | — | 0.03 Bn |
| 64 | TVGN | Tevogen Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.26 | — | 0.03 Bn |
| 65 | MRKR | Marker Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.30 | — | 0.01 Bn |
| 66 | INAB | In8Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.18 | — | 0.02 Bn |
| 67 | LGVN | Longeveron Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.88 | 17.51 | 0.01 Bn |
| 68 | GNTA | Genenta Science S.p.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.87 | — | 0.02 Bn |
| 69 | PASG | Passage BIO, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.42 | — | 0.02 Bn |
| 70 | ADIA | Adia Nutrition, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 71 | PLUR | Pluri Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.92 | 0.00 Bn |
| 72 | FBLG | FibroBiologics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.66 | — | 0.01 Bn |
| 73 | GDTC | CytoMed Therapeutics Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.25 | 40.49 | 0.01 Bn |
| 74 | SNTI | Senti Biosciences Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.14 | 543.57 | 0.01 Bn |
| 75 | ZEOX | Zeo ScientifiX, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.03 | 1.22 | 0.01 Bn |
| 76 | LNAI | Lunai Bioworks Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.06 | 96.04 | 0.01 Bn |
| 77 | PMCB | PharmaCyte Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.17 | — | 0.00 Bn |
| 78 | TPST | Tempest Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.25 | — | 0.00 Bn |
| 79 | MBIO | Mustang Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.17 | — | 0.00 Bn |
| 80 | ISCO | International Stem Cell CORP | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -8.80 | 0.29 | 0.00 Bn |
| 81 | CLDI | Calidi Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | — | 0.00 Bn |
| 82 | GNPX | Genprex, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 83 | CELZ | Creative Medical Technology Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.20 | 484.98 | 0.00 Bn |
| 84 | BRTX | BioRestorative Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | 3.36 | 0.00 Bn |
| 85 | RMTG | Regenerative Medical Technology Group Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.12 | 0.12 | 0.00 Bn |
| 86 | ERNAW | Ernexa Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 87 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 88 | PG | PROCTER & GAMBLE Co | secondary | S-10 | Household and Personal Products | SG-05 | 332.67 Bn | 20.61 | 3.82 | 322.72 Bn |
| 89 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 90 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 91 | EL | Estee Lauder Companies Inc | secondary | S-12 | Household and Personal Products | SG-05 | 35.71 Bn | 196.19 | 2.37 | 32.21 Bn |
| 92 | KVUE | Kenvue Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 34.17 Bn | 20.61 | 2.22 | 33.06 Bn |
| 93 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 94 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 95 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 96 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 97 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.45 Bn | 170.57 | 3.65 | 11.57 Bn |
| 98 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.47 Bn | -8.54 | 51.11 | 8.12 Bn |
| 99 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.77 Bn | 17.59 | 9.72 | 7.09 Bn |
| 100 | ELF | e.l.f. Beauty, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 5.93 Bn | 99.48 | 3.37 | 5.59 Bn |
| 101 | IPAR | Interparfums Inc | secondary | S-12 | Household and Personal Products | SG-05 | 3.57 Bn | 17.39 | 2.38 | 3.36 Bn |
| 102 | COTY | Coty Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 2.36 Bn | -3.81 | 0.41 | 2.18 Bn |
| 103 | PRGO | PERRIGO Co plc | secondary | S-11 | Household and Personal Products | SG-05 | 1.99 Bn | -1.15 | 0.48 | 1.59 Bn |
| 104 | GLPGF | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.73 Bn | 0.00 | 1.50 | 1.73 Bn |
| 105 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 106 | OLPX | Olaplex Holdings, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 1.39 Bn | -92.43 | 3.27 | 1.06 Bn |
| 107 | HLF | Herbalife Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 1.32 Bn | 5.18 | 0.25 | 0.95 Bn |
| 108 | EPC | EDGEWELL PERSONAL CARE Co | secondary | S-11 | Household and Personal Products | SG-05 | 1.24 Bn | -17.89 | 0.55 | 0.84 Bn |
| 109 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 110 | ODD | Oddity Tech Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.93 Bn | 12.71 | 1.26 | 0.63 Bn |
| 111 | HELE | Helen Of Troy Ltd | secondary | D-06 | Household Durables | DG-02 | 0.63 Bn | -1.54 | 0.35 | 0.61 Bn |
| 112 | HNST | Honest Company, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.60 Bn | -49.65 | 1.77 | 0.50 Bn |
| 113 | BWMX | Betterware De Mexico, S.A.P.I. De C.V | secondary | S-12 | Household and Personal Products | SG-05 | 0.58 Bn | 10.21 | 0.57 | 0.55 Bn |
| 114 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.72 | — | 0.45 Bn |
| 115 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | 3.08 | 2.13 | 0.28 Bn |
| 116 | USNA | Usana Health Sciences Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.28 Bn | -9.51 | 0.30 | 0.11 Bn |
| 117 | YSG | Yatsen Holding Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.26 Bn | -11.49 | 0.40 | 0.11 Bn |
| 118 | ALEC | Alector, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -2.87 | 18.17 | 0.08 Bn |
| 119 | NATR | Natures Sunshine Products Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 13.00 | 0.49 | 0.16 Bn |
| 120 | NUS | Nu Skin Enterprises, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.23 Bn | -1.06 | 0.17 | 0.04 Bn |
| 121 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 122 | PTNM | Pitanium Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.21 Bn | -63.51 | 24.53 | -2.70 Bn |
| 123 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.16 Bn | -1.84 | 0.67 | 0.12 Bn |
| 124 | HURA | TuHURA Biosciences, Inc./NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.18 | — | 0.13 Bn |
| 125 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.10 Bn | -0.81 | — | 0.10 Bn |
| 126 | PLYX | Polaryx Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -10.06 | — | 0.09 Bn |
| 127 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.01 | 1.21 | -0.11 Bn |
| 128 | LFVN | Lifevantage Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.08 Bn | 17.30 | 0.57 | 0.07 Bn |
| 129 | SLSN | Solesence, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.06 Bn | -23.74 | 1.03 | 0.06 Bn |
| 130 | WNW | Meiwu Technology Co Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.05 Bn | -2.84 | 7.30 | 0.03 Bn |
| 131 | ABLV | Able View Global Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.05 Bn | 13.49 | 0.46 | 0.04 Bn |
| 132 | GROV | Grove Collaborative Holdings, Inc. | secondary | S-10 | Household and Personal Products | SG-05 | 0.04 Bn | -5.39 | 0.27 | 0.03 Bn |
| 133 | MGLD | Marygold Companies, Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 0.04 Bn | -20.18 | 1.25 | 0.03 Bn |
| 134 | AXIL | Axil Brands, Inc. | secondary | D-05 | Household Durables | DG-02 | 0.04 Bn | 16.59 | 1.33 | 0.04 Bn |
| 135 | SER | Serina Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.45 | 315.10 | 0.02 Bn |
| 136 | ATNM | Actinium Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 3.44 | 1.11 | 0.04 Bn |
| 137 | INVU | Investview, Inc. | secondary | T-64 | Technology Services | TG-11 | 0.03 Bn | -2.03 | 1.32 | 0.02 Bn |
| 138 | STCB | Starco Brands, Inc. | secondary | S-04 | Branded Foods | SG-02 | 0.02 Bn | -0.96 | 0.66 | 0.02 Bn |
| 139 | CFOO | China Foods Holdings Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -75.98 | 114.41 | 0.02 Bn |
| 140 | MTEX | Mannatech Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -1.04 | 0.15 | 0.01 Bn |
| 141 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.17 | 0.02 Bn |
| 142 | LDDD | Longduoduo Co Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 143 | NHTC | Natural Health Trends Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -8.40 | 0.38 | 0.00 Bn |
| 144 | CABR | Caring Brands, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -1.08 | — | 0.01 Bn |
| 145 | ORIB | Orion Bliss Corp. | secondary | S-12 | Household and Personal Products | SG-05 | 0.01 Bn | -329.68 | 434.00 | 0.01 Bn |
| 146 | TKLF | Tokyo Lifestyle Co., Ltd. | secondary | D-36 | Retail | DG-10 | 0.01 Bn | 11.57 | 0.02 | 0.01 Bn |
| 147 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 148 | DRMA | Dermata Therapeutics, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.00 Bn | -0.59 | — | 0.00 Bn |
| 149 | JWEL | Jowell Global Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 0.00 Bn | -0.79 | 0.03 | 0.00 Bn |
| 150 | CASIF | CASI Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 151 | BCAB | BioAtla, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.07 | 0.27 | 0.00 Bn |
| 152 | GOVX | GeoVax Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 2.56 | 0.00 Bn |
| 153 | RNAZ | Transcode Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 154 | HIGR | Hi-Great Group Holding Co | secondary | S-11 | Household and Personal Products | SG-05 | 0.00 Bn | -13.55 | 24.80 | 0.00 Bn |
| 155 | GRMLW | Greenland Mines Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 156 | BYAH | Park Ha Biological Technology Co., Ltd. | secondary | S-12 | Household and Personal Products | SG-05 | 0.00 Bn | — | -2.74 | -0.01 Bn |
| 157 | NXGLW | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.02 | 0.01 | 0.00 Bn |